donate_button

New article: Progression of myelopathy in males with adrenoleukodystrophy

11th December 2018

Knowledge of the natural history of the myelopathy in ALD is paramount for evaluation of new therapies in clinical trials. The progression of myelopathy can be quantified using practical and clinically relevant outcome measures.

See the new paper from Brain Journal of neurology, by Huffnagel, van Ballegoij et al. 

Progression of myelopathy in males with adrenoleukodystrophy: towards clinical trial readiness

Facebook